GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Price-to-Funds-From-Operations

Newron Pharmaceuticals SpA (XTER:NP5) Price-to-Funds-From-Operations : (As of Dec. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Newron Pharmaceuticals SpA Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Stefan Weber Board of Directors
Dr. Ulrich Köstlin Supervisory Board